Works matching DE "DRUG interactions"
Results: 5000
Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects.
- Published in:
- CTS: Clinical & Translational Science, 2025, v. 18, n. 3, p. 1, doi. 10.1111/cts.70168
- By:
- Publication type:
- Article
Cyclin‐dependent kinase 4/6 inhibitors and cardiotoxic events in breast cancer: A pharmacovigilance study based on the FAERS database.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1404, doi. 10.1002/ijc.35255
- By:
- Publication type:
- Article
Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo‐controlled study in healthy adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 2, p. 315, doi. 10.1111/head.14853
- By:
- Publication type:
- Article
Characterization of rimegepant drug–drug interactions using the cytochrome P450 probe drugs, itraconazole, rifampin, fluconazole, and midazolam.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 2, p. 291, doi. 10.1111/head.14836
- By:
- Publication type:
- Article
Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel.
- Published in:
- Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 1, p. 14, doi. 10.1111/head.14863
- By:
- Publication type:
- Article
Development and Content Analysis Protocol for Evaluating Artificial Intelligence in Drug‐Related Information.
- Published in:
- Journal of Evaluation in Clinical Practice, 2025, v. 31, n. 1, p. 1, doi. 10.1111/jep.14276
- By:
- Publication type:
- Article
Carbapenems in the management of valproic acid overdose.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 648, doi. 10.1111/bcp.16376
- By:
- Publication type:
- Article
Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 808, doi. 10.1111/bcp.16274
- By:
- Publication type:
- Article
Management of serotonin syndrome (toxicity).
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 654, doi. 10.1111/bcp.16152
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modelling to predict potential drug–drug interactions of dersimelagon (MT‐7117).
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 451, doi. 10.1111/bcp.16271
- By:
- Publication type:
- Article
Altered bile acid and coproporphyrin‐I disposition in patients with autosomal dominant polycystic kidney disease.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 353, doi. 10.1111/bcp.16221
- By:
- Publication type:
- Article
Know the Science from the National Center for Complementary and Integrative Health (NCCIH).
- Published in:
- Journal of Consumer Health on the Internet, 2024, v. 28, n. 3, p. 261, doi. 10.1080/15398285.2024.2385880
- By:
- Publication type:
- Article
Avacopan as an add-on therapy for ANCA-associated vasculitis: a pharmacological overview.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 12, p. 1099, doi. 10.1080/17512433.2024.2432500
- By:
- Publication type:
- Article
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 10, p. 977, doi. 10.1080/17512433.2024.2410400
- By:
- Publication type:
- Article
Clinical considerations when switching antiretroviral therapy.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 7, p. 565, doi. 10.1080/17512433.2024.2365826
- By:
- Publication type:
- Article
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 7, p. 579, doi. 10.1080/17512433.2024.2363847
- By:
- Publication type:
- Article
An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV).
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 7, p. 589, doi. 10.1080/17512433.2024.2350968
- By:
- Publication type:
- Article
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 7, p. 537, doi. 10.1080/17512433.2024.2317954
- By:
- Publication type:
- Article
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 441, doi. 10.1080/17512433.2024.2343875
- By:
- Publication type:
- Article
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 4, p. 309, doi. 10.1080/17512433.2024.2317293
- By:
- Publication type:
- Article
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 2, p. 131, doi. 10.1080/17512433.2024.2305798
- By:
- Publication type:
- Article
Incidence and risk factors for potential drug-drug interactions in outpatients receiving opioid analgesics.
- Published in:
- Expert Opinion on Drug Safety, 2025, v. 24, n. 2, p. 167, doi. 10.1080/14740338.2024.2346101
- By:
- Publication type:
- Article
Drug–drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 5, p. 325, doi. 10.1080/14737140.2024.2328778
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 867, doi. 10.1002/cpt.3602
- Publication type:
- Article
Chat GPT vs. Clinical Decision Support Systems in the Analysis of Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1142, doi. 10.1002/cpt.3585
- By:
- Publication type:
- Article
Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1005, doi. 10.1002/cpt.3530
- By:
- Publication type:
- Article
Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1078, doi. 10.1002/cpt.3500
- By:
- Publication type:
- Article
Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 808, doi. 10.1002/cpt.3525
- By:
- Publication type:
- Article
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 732, doi. 10.1002/cpt.3506
- By:
- Publication type:
- Article
A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 716, doi. 10.1002/cpt.3504
- By:
- Publication type:
- Article
Leveraging Real‐World Data to Address Potential Methadone Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 321, doi. 10.1002/cpt.3520
- By:
- Publication type:
- Article
French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 387, doi. 10.1002/cpt.3502
- By:
- Publication type:
- Article
Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 523, doi. 10.1002/cpt.3482
- By:
- Publication type:
- Article
Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 421, doi. 10.1002/cpt.3479
- By:
- Publication type:
- Article
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 403, doi. 10.1002/cpt.3477
- By:
- Publication type:
- Article
Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 506, doi. 10.1002/cpt.3471
- By:
- Publication type:
- Article
The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 495, doi. 10.1002/cpt.3469
- By:
- Publication type:
- Article
Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Studies Related to Vincristine‐Induced Peripheral Neuropathy in Chinese Pediatric ALL Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 454, doi. 10.1002/cpt.3462
- By:
- Publication type:
- Article
Lenacapavir: Playing the Long Game in the New Era of Antiretrovirals.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 353, doi. 10.1002/cpt.3447
- By:
- Publication type:
- Article
Effects of GLPG3970 on Sulfasalazine and Methotrexate Pharmacokinetics in Healthy Adults: Two Open‐Label, Phase I, Drug–Drug Interaction Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 427, doi. 10.1002/cpt.3438
- By:
- Publication type:
- Article
Utility of Biomarker‐Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 398, doi. 10.1002/cpt.3436
- By:
- Publication type:
- Article
Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 2, p. 91, doi. 10.1002/cpdd.1491
- By:
- Publication type:
- Article
Impact of Acid‐Reducing Agents on Sotorasib Pharmacokinetics and Potential Mitigation of the Impact by Coadministration With an Acidic Beverage.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 2, p. 167, doi. 10.1002/cpdd.1489
- By:
- Publication type:
- Article
Real‐Practice Analysis of Potential Antibiotic Interactions in Patients Treated With Immune Checkpoint Inhibitors: An Observational Study From an Italian Referral Cancer Center.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2025, v. 2025, p. 1, doi. 10.1155/jcpt/5572209
- By:
- Publication type:
- Article
Synergy detection: A practical guide to statistical assessment of potential drug combinations.
- Published in:
- Pharmaceutical Statistics, 2025, v. 24, n. 1, p. 1, doi. 10.1002/pst.2383
- By:
- Publication type:
- Article
The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers.
- Published in:
- Pharmacotherapy, 2025, v. 45, n. 2, p. 94, doi. 10.1002/phar.4641
- By:
- Publication type:
- Article
PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 130, doi. 10.1002/psp4.13249
- By:
- Publication type:
- Article
The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 95, doi. 10.1002/psp4.13244
- By:
- Publication type:
- Article
MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model‐informed analysis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 2, p. 376, doi. 10.1002/psp4.13282
- By:
- Publication type:
- Article
Establishing a physiologically based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase‐CYP substrates.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 164, doi. 10.1002/psp4.13255
- By:
- Publication type:
- Article